LU84640A1 - NEW PROCESS FOR OBTAINING VINCRISTINE AND VINCRISTINE SULFATE - Google Patents
NEW PROCESS FOR OBTAINING VINCRISTINE AND VINCRISTINE SULFATE Download PDFInfo
- Publication number
- LU84640A1 LU84640A1 LU84640A LU84640A LU84640A1 LU 84640 A1 LU84640 A1 LU 84640A1 LU 84640 A LU84640 A LU 84640A LU 84640 A LU84640 A LU 84640A LU 84640 A1 LU84640 A1 LU 84640A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- vincristine
- vinblastine
- reaction medium
- solution
- permanganate
- Prior art date
Links
- 229960004528 vincristine Drugs 0.000 title claims abstract description 26
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 title claims abstract description 26
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 22
- AQTQHPDCURKLKT-JKDPCDLQSA-N vincristine sulfate Chemical compound OS(O)(=O)=O.C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C=O)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 AQTQHPDCURKLKT-JKDPCDLQSA-N 0.000 title description 3
- 229960002110 vincristine sulfate Drugs 0.000 title description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000002253 acid Substances 0.000 claims abstract description 10
- 239000012429 reaction media Substances 0.000 claims abstract description 6
- 150000002500 ions Chemical class 0.000 claims abstract description 4
- 239000002904 solvent Substances 0.000 claims description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 2
- 150000003863 ammonium salts Chemical class 0.000 claims 2
- 239000012431 aqueous reaction media Substances 0.000 claims 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 abstract description 16
- 229960003048 vinblastine Drugs 0.000 abstract description 14
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 abstract description 6
- 150000003839 salts Chemical class 0.000 abstract description 6
- 239000012286 potassium permanganate Substances 0.000 abstract description 2
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 abstract 2
- 239000004721 Polyphenylene oxide Substances 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 229920000570 polyether Polymers 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 11
- 238000007254 oxidation reaction Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000003647 oxidation Effects 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical class [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical class CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- VBQDSLGFSUGBBE-UHFFFAOYSA-N benzyl(triethyl)azanium Chemical compound CC[N+](CC)(CC)CC1=CC=CC=C1 VBQDSLGFSUGBBE-UHFFFAOYSA-N 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- -1 ethyl ethyl group Chemical group 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 150000002696 manganese Chemical class 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 150000003109 potassium Chemical class 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- CXBGOBGJHGGWIE-IYJDUVQVSA-N vindoline Chemical group CN([C@H]1[C@](O)([C@@H]2OC(C)=O)C(=O)OC)C3=CC(OC)=CC=C3[C@]11CCN3CC=C[C@]2(CC)[C@@H]13 CXBGOBGJHGGWIE-IYJDUVQVSA-N 0.000 description 2
- RDSFGYBJMBTKMN-UHFFFAOYSA-N 1,4,7,10,13-pentaoxacyclooctadecane Chemical compound C1CCOCCOCCOCCOCCOCC1 RDSFGYBJMBTKMN-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- 206010011416 Croup infectious Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- JXLYSJRDGCGARV-PJXZDTQASA-N Leurosidine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-PJXZDTQASA-N 0.000 description 1
- WVTGEXAIVZDLCR-UHFFFAOYSA-N Vindoline Natural products CC1C2CN3CCCC14CCC5Nc6ccccc6C25C34 WVTGEXAIVZDLCR-UHFFFAOYSA-N 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- JXLYSJRDGCGARV-KSNABSRWSA-N ac1l29ym Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-KSNABSRWSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940054720 avage Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- GKWYINOZGDHWRA-UHFFFAOYSA-N catharanthine Natural products C1C(CC)(O)CC(CC2C(=O)OC)CN1CCC1=C2NC2=CC=CC=C12 GKWYINOZGDHWRA-UHFFFAOYSA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 201000010549 croup Diseases 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- ZPKLYVJENOZRAW-UHFFFAOYSA-L iron(2+);dichlorate Chemical compound [Fe+2].[O-]Cl(=O)=O.[O-]Cl(=O)=O ZPKLYVJENOZRAW-UHFFFAOYSA-L 0.000 description 1
- 229910000462 iron(III) oxide hydroxide Inorganic materials 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-M leucinate Chemical compound CC(C)CC(N)C([O-])=O ROHFNLRQFUQHCH-UHFFFAOYSA-M 0.000 description 1
- LBSANEJBGMCTBH-UHFFFAOYSA-N manganate Chemical compound [O-][Mn]([O-])(=O)=O LBSANEJBGMCTBH-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- KGKWFGPHYYEERW-UHFFFAOYSA-N velbanamine Chemical group C1CC2(C(C3)C(O)=O)N(C(=O)OC)C4=CC=CC=C4C22C4C31CCCN4CC2 KGKWFGPHYYEERW-UHFFFAOYSA-N 0.000 description 1
- KDQAABAKXDWYSZ-PNYVAJAMSA-N vinblastine sulfate Chemical class OS(O)(=O)=O.C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 KDQAABAKXDWYSZ-PNYVAJAMSA-N 0.000 description 1
- 229960004982 vinblastine sulfate Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
I t ] t lI t] t l
! NOUVEAU PROCEDE D'CBTENTICN DE LA. VEJCRISTIKE! NEW PROCESS FOR BTENING OF THE. VEJCRISTIKE
ET DU SULFATE DE VINCRISTINEAND VINCRISTINE SULFATE
il ' -------- ---------- il si il ij La présente invention concerne un nouveau procédé d1 obtention de la ;ï vincristine par oxydation sélective du groupe N-c.éthyle de la vin- ,*1 blastine.The present invention relates to a new process for obtaining vincristine by selective oxidation of the ethyl ethyl group of wine. , * 1 blastine.
i ί ij La vincristine est un alcaloïde fcis-indolique répondant à la formule i ] I dans laquelle R représente un groupe forcyle.i ί ij Vincristine is an fcis-indole alkaloid corresponding to the formula i] I in which R represents a forcyl group.
•i . OH• i. OH
!: otf!: otf
MeO,C \ ! . CH„0 [ J‘^n- (I) > 1 1 R CrsCH, - j i.MeO, C \! . CH „0 [J‘ ^ n- (I)> 1 1 R CrsCH, - j i.
le vincristine est utilisée en chimiothérapie anticancéreuse en particulier pour le tr ai tarent de certaines laucsr_.es avoues.vincristine is used in anticancer chemotherapy, in particular for the treatment of certain declared laucsr_.es.
. Cet alcaloïde est obtenu principalement par extrac-'or. 2 oartir de ; feuilles ce Catiarar.thus Roseus (brevet ces Etats-· ois ~° 3 205 22 h où il se trouve acxxrpagr.ë d’autres alcaloïdes bis-incm'’ en particulier la Vinblastine. La Vinblastine (I, p _ o^t oetendin- présenre à une concentration très supérieure à ce;i5 ~s vincristine et constitue donc un précurseur de choix pour l’hérysv-th^se de cetta ; dernière.. This alkaloid is obtained mainly by extrac-'or. 2 start from; leaves this Catiarar.thus Roseus (patent these States · ° ~ 3 205 22 h where there is acxxrpagr.ë other alkaloids bis-incm '' in particular Vinblastine. Vinblastine (I, p _ o ^ t oetendin- present at a concentration much higher than this; i5 ~ s vincristine and therefore constitutes a precursor of choice for the hérysv-th ^ se of cetta; last.
] / i 2.] / i 2.
j ! 1 Plusieurs procédés de fabrication de la vincristine à partir de la vinblastina ont été divulgués, 'tous relevons notamment I les brevets ou demandes ce brevets suivants : • i - | | a) brevet beige 793.337 (Sichter Geceon) qui décrit une i méthode d’oxvdation de la Vinblastine en vincristine par J un mélange acide erratique, acide acétique et acétone.j! 1 Several processes for the production of vincristine from vinblastina have been disclosed, all of which include: I the following patents or applications for this patent: • i - | | a) beige patent 793,337 (Sichter Geceon) which describes a method for the oxidation of Vinblastine to vincristine by J a mixture of erratic acid, acetic acid and acetone.
I b) brevet belge S23.560 (Richter Gedeon) : l'oxydation est I effectuée par l'oxygène dans l'acide ferrique et en présence f, d'un -catalyseur à base de platiner., à têmoerature ambiante.I b) Belgian patent S23.560 (Richter Gedeon): the oxidation is carried out by oxygen in ferric acid and in the presence f of a platinum-based catalyst at ambient temperature.
i !i!
'•H'• H
l z c) demande ce brevet: européen 18 231 (Richter éedeen} : ί l'oxydation est effectuée par l'acide chronique ou un ' „ cichrarace de métal alcalin en présence d*anhydride acétique 1 et éventuellement d'éthanol.01 d,ii~ solvant crcaniaue v- immiscible à l'eau.lzc) applies for this patent: European 18 231 (Richter éedeen}: ί the oxidation is carried out by chronic acid or an alkali metal cichrarace in the presence of acetic anhydride 1 and optionally ethanol. 01 d, ii ~ crcaniaue solvent v- immiscible with water.
i l d) cenande ce brevet européen n° 37.289 (Ξ11 Lilly) : ! *! ! l'oxydation est effectuée par le per chlorate de fer (II) en présence de perexide d'hydrogène et d'acétone tri lei l d) apply for this European patent n ° 37.289 (Ξ11 Lilly):! *! ! the oxidation is carried out with per (II) iron chlorate in the presence of hydrogen perexide and tri acetone
De plus, la demande de brevet européen 37.292 décrit un procédé d' oxydation de la Vinblastine base avec \'a?Cr907 en présence d'acide sulfurique cars le titraiyerefuranne.In addition, European patent application 37.292 describes a process for the oxidation of Vinblastine base with a? Cr907 in the presence of sulfuric acid like titraiyerefuranne.
Cette réaction conduite à -5CcC est effectuée avec un rendement de 80-92 % calculé par dosage.This reaction, carried out at -5 ° C., is carried out with a yield of 80-92% calculated by assay.
' i les rerderer.ts observés ou la pureté des produits obtenus caractéris ant les procédés décrits ci-desrus ccrstrtuent cependant ï , ces désavantages imoortants. Un produit seccrdaire fréquemment ferré ! ;'i the observed rerderer.ts or the purity of the products obtained characterizing ant the processes described above ccrstrtuent ï, these imoortant disadvantages. A frequently shoddy secretary product! ;
: ‘ JS: ‘JS
* s J ‘Ί îr~~ ! /* s J ‘Ί îr ~~! /
1 V1 V
3t.3t.
, î ' : , est la N-cém.éthvl Vinblastine qu'il faut alors reforiavler, î ':, is the N-cém.éthvl Vinblastine which must then be reforiavler
Ipour obtenir la vincristine.I to get vincristine.
Le procédé de la présente invention nernet ce produire la vincristine de manière simple en auantité importante ! et â un decré de pureté n'exiaeant peu ou pas ce ourifi- ai » · s - cation supplémentaire par recristallisation ou chronato- | graphie.The process of the present invention nernet that produce vincristine in a simple way in significant amount! and at a decreed of purity which little or no attenuates this ourification - additional cation by recrystallization or chronato- | spelling.
£ | I Le réactif d'oxydation utilisé est l'ion permanganate J solubilisé dans un solvant aromatique ou un solvant ! ’ orcanirrue chloré. Une alternative consiste è .1 immobiliser l'anion permanganate sur un résine/ par ;; ’ exemple un oolvm&re du t^oe Dolvstvr^ne comprenant des croupes ammoniums.£ | I The oxidation reagent used is the permanganate ion J solubilized in an aromatic solvent or a solvent! Chlorinated orcanirrue. An alternative is to immobilize the permanganate anion on a resin / par ;; Example an oolvm & re of the Dolvstvr ^ head comprising ammonium croups.
t i ’ La solubilisation peut erre effectuée par l'action d'un ** i; acent complexant du tvoe éther-couronne ("crovn-ether") j sur le Dermancanate ce potassium.t i ’The solubilization can be carried out by the action of a ** i; acent complexing tvoe crown ether ("crovn-ether") j on Dermancanate this potassium.
" L'anion permanganate peut écalement être solubilisé en préparant un sel d'ammonium ou de phoshonium. quaternaire ; correspondant qui est soluble dans un solvant organique, en particulier un solvant orcaniaue chloré tel aue le dichiorométhane. Bans ce but, on utilisera ce préférence le oermancanate de benzvltriëthvlammonium;."The permanganate anion can also be dissolved by preparing an ammonium or phoshonium salt. Quaternary; corresponding which is soluble in an organic solvent, in particular an organic chlorinated solvent such as dichioromethane. For this purpose, this preference will be used benzvltriëthvlammonium oermancanate ;.
• h :¾ L'obtention de vincristine ~ partir ce la Vinblastine en i utilisant un sel ce Permanganate est inattendue dans la mesure ou le oermancanate ce potassium utilisé dans 1'acétone oxvde certains dérivés de la Vinblastine au niveau ce la partie velbanamine de la molécule (Kutnev, Balsevich et '»»orth, Heterocvcles, 11, 69, 197P) . Le groupe N-méthyl ce la Partie vindoline reste intact.• h: ¾ Obtaining vincristine ~ from this Vinblastine using i a salt this Permanganate is unexpected since the oermancanate this potassium used in acetone oxvde certain derivatives of Vinblastine at the level of the velbanamine part of the molecule (Kutnev, Balsevich and '»» orth, Heterocvcles, 11, 69, 197P). The N-methyl group that the Vindoline part remains intact.
/ La formation d'un croupe ΐΤ-ΓΗΟ sur un squelette bis-inccle ^ eu croûte ce la Vinblastine ,en utilisant un sel ce per- 4 ,· ! manganate n'a iairais été signalée./ The formation of a rump ΐΤ-ΓΗΟ on a bis-inccle skeleton ^ had crust this Vinblastine, using a salt this per- 4, ·! manganate has not been reported.
i m J Selon un mode du procédé de la présente invention, la ;| vinblastine, de préférence sous la forme ce sulfate, J est traitée en présence d'un acide crganicue tel l'acide acétiaue, avec un exces de permanganate ce potassium dissous ;! dans un solvant oraanicrue chloré ou le toluène en présence || de "l^-crown-ô" éther ou les dérivé cibenzo- ou cicyclohexyl- !$ correspondants. La réaction est menée à une température iii :« comprise entre -40°C et -^5°C et est avantageusement suivie ί en chromatocraonie sur couche mince. Le terres de réaction * varie généralement de 5 minutes è 3 heures.i m J According to one mode of the process of the present invention, the; | vinblastine, preferably in the form of this sulfate, J is treated in the presence of a crganic acid such as acetic acid, with an excess of permanganate, this dissolved potassium; in a chlorinated oraanicrue solvent or toluene in the presence || of "l ^ -crown-ô" ether or the corresponding cibenzo- or cicyclohexyl-! $ derivatives. The reaction is carried out at a temperature iii: "between -40 ° C and - ^ 5 ° C and is advantageously followed ί by chromatography on a thin layer. The reaction grounds * generally vary from 5 minutes to 3 hours.
Le permanganate de potassium est ce préférence dissous dans le dichlorométhane et la réaction d*oxydation est .-i. " alors effectuée * -70°f!.Potassium permanganate is this preference dissolved in dichloromethane and the oxidation reaction is.-I. "then performed * -70 ° f !.
l'j,l'j,
La solubilité du permanaanate de potassium, est en effet substantiellement augmentée en présence d'un pclvéther macrocvcliaue tel le "18-crown-5" éther (1,4,7,10,13,16-hexacxacvclooctadécane) ou le dérivé dibenzo- ou dieveie-hexvl correspondant.The solubility of potassium permanaanate is in fact substantially increased in the presence of a macrocyclic pclvether such as "18-crown-5" ether (1,4,7,10,13,16-hexacxacvclooctadecane) or the dibenzo- or derivative corresponding dieveie-hexvl.
Le mélange réactionnel est ensuite simultanément traité par un réducteur doux et alcalir.isé. Dans ce but on utilisera de préférence une solution acueuse ce bisulfite de sodium 1 er de 1'ammcniaaue.The reaction mixture is then simultaneously treated with a soft reducer and alkalized. For this purpose, an aqueous solution is preferably used, this sodium bisulfite 1 st of the ammonia.
__ ta phase organiaue est séparée et la phase aqueuse est • extraite plusieurs fois par le chlorure de méthvlène. Les phases organiques réunies sont concentrées sous vide pour fournir un résidu comportant 80-85 % de vincristine base / soit un rendement de 90-95 %.__ your organ phase is separated and the aqueous phase is • extracted several times with methylene chloride. The combined organic phases are concentrated under vacuum to provide a residue comprising 80-85% of vincristine base / ie a yield of 90-95%.
<: > !'· / __ 5 jî :1 ij Alternativement on Deut procéder à l'extraction du !1 ij * milieu réactionnel après réduction sans procéder if îi è une alcalinisation simultanée. La solution aoueuse 1 acide est alors extraite par le dichloronéthar.e. Cette .ij voie constitue un procédé original de purification • de la vincristine formée dans le milieu réactionnel.<:>! '· / __ 5 jî: 1 ij Alternatively, the! 1 ij * reaction medium may have to be extracted after reduction without proceeding with simultaneous alkalization. The acidic 1 acid solution is then extracted with dichloronethar. This .ij route constitutes an original process for the purification of the vincristine formed in the reaction medium.
•! Selon un autre mode de réalisation de la présente invention, la vincristine est obtenue par oxvdation de la vinblasti ne par action d'un permanganate d'ammonium Quaternaire. Le cation ammonium est de ' préférence le arouoe benzvltriéthvlammonium ou benzvl- ; - trirrethvl ammonium. ( voir p.e. Ancew. Chem.,Intern.Ed.•! According to another embodiment of the present invention, vincristine is obtained by oxidation of vinblasti ne by the action of a quaternary ammonium permanganate. The ammonium cation is preferably arouoe benzvltriéthvlammonium or benzvl-; - trirrethvl ammonium. (see e.g. Ancew. Chem., Intern.Ed.
i l?, 1^0 , 1^4 ) . La réaction est effectuée en 2 à 6 h à -60 °C dans un mélance de dichlorométhane et d'acide ! acétiaue clacial. Après traitement nar un aaent réducteur doux en milieu aaueux, la solution acide i résultante est extraite car le dichlorométhane ouïs i .i l ?, 1 ^ 0, 1 ^ 4). The reaction is carried out in 2 to 6 h at -60 ° C in a mixture of dichloromethane and acid! clacial acetaria. After treatment with a mild reducing agent in an aqueous medium, the resulting acid solution i is extracted because the dichloromethane is i.
la nn-'se orçaniQue est alcalimsee par ±avage ‘ solution aaueuse basicue et concentrée. La vincristine solvatée est isolée avec un rendement supérieur è 90 %.nn-'se orçaniQue is alkalized by ± avage ‘aqueous solution basic and concentrated. The solvated vincristine is isolated with a yield greater than 90%.
Γ-ans la plupart ces cas, la vincristine ainsi obtenue ! peut être directement transformée en un sel d'addition - d'acice organiaue ou minéral, de préférence un sel oharm.aceutiQuement acceptable.Γ-years in most cases, vincristine thus obtained! can be directly transformed into an addition salt - of organic or inorganic acid, preferably an acharmically acceptable salt.
En particulier le sulfate de vincristine est obtenu par addition ce é une solution de vincristine base brute ou recristallisée car.s l'éthanol, dissous dans un mélange chlorure de méthviène-éthancl anhvdre, élimination partielle sous vide du chlorure de méthylène et cristallisation.In particular, vincristine sulphate is obtained by adding ce to a crude or recrystallized base vincristine solution because of ethanol, dissolved in an anhydrous methviene chloride-ethancl mixture, partial removal of the methylene chloride under vacuum and crystallization.
Le sulfate ce vincristine ainsi obtenu présente un decré » de pureté suffisant pour être utilisé comme médicament, J en particulier sous forme ce soluté injectable.The sulfate this vincristine thus obtained has a decre »of purity sufficient to be used as a medicament, J in particular in the form of this injectable solute.
il 6' il ILe procédé d'oxydation décrit dans la Drésente invention * peut également être apolicrué à d'autres alcaloïdes bis- i indolicues possédant un aroune N-réthvle analoaue è la % -il 6 'il ILoxidation process described in the present invention * can also be apolicrué to other bis-i indolic alkaloids having an aroune N-rethvle analoaue à la% -
vindoline. La leurosidine ou la désox^-4'Vinblastine A ou Bvindoline. Leurosidine or deox ^ -4'Vinblastin A or B
jj ’ peuvent ainsi être transformée en dérivé N-formvl cor- resoondant . La méthode oeut également être utilisée pour i obtenir la N-formvl leurosine oui est particulièrement '! 4 active comme aaent anti-tumoral. Eventuellement, le :| nouveau Drocédé d'obtention sera aoolicué aux dérivés l-:i ! . bis-indoliaues du tvpe de la Vinblastine cssacétvlés en position 0-4, le orouDe hvdroxvle restant inerte dans || les conditions d'oxvdation utilisées. Cette méthode * peut en particulier être utilisée nour l'obtention ce dérivé n-formvl de Vinblastine conjuguée avec des acides aminés ou des oeptices, p. e. le N-vmblastinoyl-2 3 leucinate d'éthvle .jj ’can thus be transformed into a corresponding N-formvl derivative. The method can also be used to obtain N-formvl theirosin yes is particularly '! 4 active as an anti-tumor agent. Optionally, the: | new procurement process will be added to derivatives l-: i! . bis-indoliaues of the Vinblastine tvpe cssacétvlés in position 0-4, the hvdroxvle orouD remaining inert in || the oxvdation conditions used. This method * can in particular be used nour obtaining this n-formvl derivative of Vinblastine conjugated with amino acids or oeptices, p. e. N-vmblastinoyl-2 3 ethvl leucinate.
!; EXEMPLES!; EXAMPLES
ii
Formation de vincristine par oxydation au EMnC „ ce la VLB.Vincristine formation by oxidation at EMnC „ce VLB.
HH
Une solution de 2,73 g de sulfate ce Vinblastine dans 330 ml ce chlorure de m.éthvlêne et 42 ml d'acide acétique est déparée par barbottage c'argon pendant 30 minutes a tempéra tore ambrante puis refroidie â-7C°C.A solution of 2.73 g of this Vinblastine sulfate in 330 ml of methylene chloride and 42 ml of acetic acid is sparged with argon for 30 minutes at room temperature and then cooled to -7 ° C.
Cr. additionne coutte à croutte une solu.tror. ce 1,0/ g es ΕΜηΟ„Cr. add solu.tror to crust. ce 1,0 / g es ΕΜηΟ „
·" ~ *X· "~ * X
dans 125 ml âs chlorure de méthylène et 2,22 g de 1,4,7,10,13,16- i hsxacxacycioactadecane (iS-crown—6). La réaction est suivre ’i' et contrôlée en CCM (plaque de Silice - élutior. einer SO - y ' I méthane! 20).in 125 ml of methylene chloride and 2.22 g of 1,4,7,10,13,16-i hsxacxacycioactadecane (iS-crown — 6). The reaction is followed ’i’ and controlled by TLC (Silica plate - elutior. Einer SO - y ’methane! 20).
^__ ' / Î ^ 7 » Le milieu réactionnel est ensuite versé sur un mélange refroidi et agité (consistance pâteuse) de 220 ml de solution aqueuse de | bisulfite de sodium à 5 % et de 110 ml d'arrxriaçue 14 N.The reaction medium is then poured onto a cooled and stirred mixture (pasty consistency) of 220 ml of aqueous solution of | 5% sodium bisulphite and 110 ml of 14 N arrriaque.
!j i | ; I L'émulsion éventuelle due à la présence ce dioxyde ce manganèse i| est traité par filtration du mélange total sur terre de diatcrées.! j i | ; I The possible emulsion due to the presence of this dioxide this manganese i | is treated by filtration of the total mixture on earth of diatrates.
11 Les deux phases claires sont décantées et la phase aqueuse est j 1 * .11 The two clear phases are decanted and the aqueous phase is 1 *.
ί j épuisée par le chlorure de méthylène. Les extraits sont réunis, l| séchés sur higSQ, et évaporés à sec (Poids : 2,93 g).ί j exhausted by methylene chloride. The extracts are gathered, l | dried on higSQ, and evaporated to dryness (Weight: 2.93 g).
k <! i i Le résidu est dosé à 83 % de vincristine base soit un rendement * de 56 %.k <! i i The residue is dosed at 83% vincristine base, ie a yield * of 56%.
•} La vincristine base est obtenue par cristallisation du résidu dans l'éthanol et est identique à un échantillon authentique ! ce référence (sœctre de masse, sœctre UV, spectre BMï ^H).•} Vincristine base is obtained by crystallization of the residue in ethanol and is identical to an authentic sample! this reference (mass sector, UV sector, BMI ^ H spectrum).
il Dhe d
Ïïj ! Sulfate :Ïïj! Sulfate:
La vincristine base est solubilisée dans un mélange de CH^Cl^ et d'éthanol (60 : 40) * Le pH est ajusté à 4,00 par addition d'une solution à 1,84 % d'ILSCb dans l'éthanol anhydre.Vincristine base is dissolved in a mixture of CH ^ Cl ^ and ethanol (60:40) * The pH is adjusted to 4.00 by adding a 1.84% solution of ILSCb in anhydrous ethanol .
. / *4 | Le solvant est partiellement éliminé par distilla tien sens vide et le sulfate cristallise lentement par agitation de la - solution à température ambiante.. / * 4 | The solvent is partially removed by distillation in an empty sense and the sulfate slowly crystallizes by stirring the solution at room temperature.
i ί*χ—"" i.! / / * fi 1 11 8 i I 1 - formation de la vincristine car oxvdation de la jVinblastine en présence de permanganate de benzvl- i j triethv1ammonium.i ί * χ— "" i.! / / * fi 1 11 8 i I 1 - formation of vincristine because oxvdation of jVinblastine in the presence of benzvl-iang triethv1ammonium permanganate.
j ff j Dans un ballon de 4 L, on Place 20 g de sulfate dej ff j In a 4 L flask, place 20 g of sulphate
Vinblastine dans 1,6 L ce dichlororêthane. <~>n ajoute 360 m.L d'acide acétinue sec oui solubilise la Vinblastine . On refroidît sous atmosphère d'argon è -60°C.Vinblastine in 1.6 L this dichloroethane. <~> n adds 360 ml of dry acetinic acid yes solubilizes Vinblastine. Cooled under an argon atmosphere at -60 ° C.
Une solution de 27,68 σ de Demancranate de benzvltri-éthvlammoniun dans 1,6 L de dichloromêthar.e est , ' préparée. Cette solution est filtrée sur papier afin i ,| d'éliminer un éventuel précipité de dioxvde ce manganèse.A 27.68 σ solution of benzvltri-ethvlammoniun demancranate in 1.6 L of dichloromêthar is prepared. This solution is filtered on paper so i, | to eliminate a possible precipitate of dioxin from this manganese.
|i On additionne la solution oxvdanie ooutte à goutte ; . sans dépasser -60°C. L'addition est effectuée en 3 heures.| i Add the drop by drop oxvdanie solution; . without exceeding -60 ° C. The addition is carried out in 3 hours.
On refroidit jusru'è l'état pâteux une solution ce 3,9 L de bisulfite de sodium è 5%. Or. transfère, sous pression > c ' arcor. le relance réactionnel dans la solution de bisuroite oui est acitée mécaniquement. On laisse revenir à température ambiante et la phase aaueuse est épuisée par le dichlorc-méthane (3,7 L initialement, puis 3 L,puis deux fois 2L).A 3.9 cc solution of 5% sodium bisulfite is cooled to a pasty state. Or. Transfers, under pressure> c 'arcor. the reaction recovery in the bisuroite solution yes is mechanically activated. The mixture is left to return to ambient temperature and the aqueous phase is exhausted with dichlorc-methane (3.7 L initially, then 3 L, then twice 2L).
Les phases orcaniaues réunies sont alcalinis£es par addition ce 7 L ce bicarbonate ce sodium à 80 g/L. Le dichlororêthane est alors £v&r>orê sous vide. On obtient ainsi 16,47 ç ce vincristine brute. Après s£chaae sous vide pendant 17 heures * température ambiante, on croient 15,17 g de •vincristine de cureté supérieure ? 92 %.The combined organic phases are made alkaline by adding this 7 L to this sodium bicarbonate at 80 g / L. The dichloroethane is then £ v & r> oré under vacuum. This gives 16.47 ç this crude vincristine. After drying under vacuum for 17 hours at room temperature, we believe 15.17 g of • vincristine of higher curity? 92%.
/ i fp./ i fp.
^ V __ / / / / w/^ V __ / / / / w /
Claims (5)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU84640A LU84640A1 (en) | 1983-02-10 | 1983-02-10 | NEW PROCESS FOR OBTAINING VINCRISTINE AND VINCRISTINE SULFATE |
| ES529562A ES8506033A1 (en) | 1983-02-10 | 1984-02-08 | Process for the preparation of vincristine. |
| AT84870018T ATE31311T1 (en) | 1983-02-10 | 1984-02-09 | PROCESS FOR PRODUCTION OF VINCRISTIN. |
| EP84870018A EP0117861B1 (en) | 1983-02-10 | 1984-02-09 | Process for the preparation of vincristine |
| ZA84963A ZA84963B (en) | 1983-02-10 | 1984-02-09 | Method of obtaining vincristine and vincristine sulfate and products thus obtained |
| HU84526A HU189817B (en) | 1983-02-10 | 1984-02-09 | Process for preparing vincristine and addition salts thereof |
| JP59022703A JPS59152390A (en) | 1983-02-10 | 1984-02-09 | Manufacture of vincristine and vincristine sulfate |
| DE8484870018T DE3468028D1 (en) | 1983-02-10 | 1984-02-09 | Process for the preparation of vincristine |
| IL70998A IL70998A (en) | 1983-02-10 | 1984-02-17 | Method of obtaining vincristine and its addition salts and products thus obtained |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU84640A LU84640A1 (en) | 1983-02-10 | 1983-02-10 | NEW PROCESS FOR OBTAINING VINCRISTINE AND VINCRISTINE SULFATE |
| LU84640 | 1983-02-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU84640A1 true LU84640A1 (en) | 1984-11-08 |
Family
ID=19730034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU84640A LU84640A1 (en) | 1983-02-10 | 1983-02-10 | NEW PROCESS FOR OBTAINING VINCRISTINE AND VINCRISTINE SULFATE |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0117861B1 (en) |
| JP (1) | JPS59152390A (en) |
| AT (1) | ATE31311T1 (en) |
| DE (1) | DE3468028D1 (en) |
| ES (1) | ES8506033A1 (en) |
| HU (1) | HU189817B (en) |
| IL (1) | IL70998A (en) |
| LU (1) | LU84640A1 (en) |
| ZA (1) | ZA84963B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2582651B1 (en) * | 1985-06-03 | 1987-08-28 | Pf Medicament | PROCESS FOR THE PREPARATION OF VINCRISTINE |
| FR2651348B1 (en) * | 1989-08-04 | 1993-01-22 | Adir | |
| CN101362771B (en) * | 2008-09-26 | 2010-12-08 | 深圳万乐药业有限公司 | Method for preparing high purity vincristine sulfate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU178706B (en) * | 1979-04-23 | 1982-06-28 | Richter Gedeon Vegyeszet | Process for preparing bis-indole alkaloids and acid addition salts thereof |
| US4303584A (en) * | 1980-04-02 | 1981-12-01 | Eli Lilly And Company | Method of preparing vincristine |
| HU183385B (en) * | 1980-04-02 | 1984-04-28 | Lilly Co Eli | Process for preparing vinca dimer derivatives |
-
1983
- 1983-02-10 LU LU84640A patent/LU84640A1/en unknown
-
1984
- 1984-02-08 ES ES529562A patent/ES8506033A1/en not_active Expired
- 1984-02-09 JP JP59022703A patent/JPS59152390A/en active Granted
- 1984-02-09 HU HU84526A patent/HU189817B/en not_active IP Right Cessation
- 1984-02-09 AT AT84870018T patent/ATE31311T1/en not_active IP Right Cessation
- 1984-02-09 DE DE8484870018T patent/DE3468028D1/en not_active Expired
- 1984-02-09 ZA ZA84963A patent/ZA84963B/en unknown
- 1984-02-09 EP EP84870018A patent/EP0117861B1/en not_active Expired
- 1984-02-17 IL IL70998A patent/IL70998A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL70998A (en) | 1986-12-31 |
| ATE31311T1 (en) | 1987-12-15 |
| ZA84963B (en) | 1984-09-26 |
| ES529562A0 (en) | 1985-07-01 |
| EP0117861A1 (en) | 1984-09-05 |
| JPH041758B2 (en) | 1992-01-14 |
| ES8506033A1 (en) | 1985-07-01 |
| EP0117861B1 (en) | 1987-12-09 |
| HU189817B (en) | 1986-08-28 |
| DE3468028D1 (en) | 1988-01-21 |
| JPS59152390A (en) | 1984-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH639070A5 (en) | 4- (DI-N-PROPYL) AMINO-1,3,4,5-TETRAHYDROBENZO (CD) INDOLE AND PHARMACEUTICAL COMPOSITION CONTAINING IT. | |
| CA2747105C (en) | Method for preparing activated esters | |
| EP0117861B1 (en) | Process for the preparation of vincristine | |
| EP0044238B1 (en) | Cephalosporin sulfoxides, process for their preparation and pharmaceutical compositions containing them | |
| EP2376496B1 (en) | Synthesis of morphine-6-glucuronide or of a derivative thereof | |
| EP0101383A1 (en) | 14-Amino-steroid derivatives, their therapeutical use and process for their preparation | |
| CA1210762A (en) | Method of producing vincristine | |
| CH620688A5 (en) | Process for the preparation of new lactones derived from cyclopentanol | |
| EP0432029B1 (en) | Process for the preparation of synergistins | |
| CH407147A (en) | Process for the preparation of anti-tumor compounds | |
| EP0170937B1 (en) | Double salt of desoxyfructosyl-serotonine and of creatinine, its preparation and medicaments containing it | |
| EP0821697A1 (en) | Method for preparing streptogramines | |
| CH474501A (en) | Process for the preparation of a furan derivative | |
| CH400177A (en) | Process for preparing alkaloids | |
| MC1849A1 (en) | PROCESS FOR THE MANUFACTURE OF 1-METHYL-10 METHOXYLUMILYSERGOL ESTERS | |
| CA2148880A1 (en) | 5,6-dihydro-4h-thieno[3,4-c]pyrrole derivatives; process for preparing the same and their use as therapeutic agents | |
| FR2667065A1 (en) | PROCESS FOR PREPARING 1 - [(2S) -3-MERCAPTO-2-METHYL-1-OXOPROPYL] -L-PROLINE | |
| MC513A1 (en) | New derivatives of semicarbazide and their preparation | |
| CH645120A5 (en) | PROCESS FOR THE PREPARATION OF VINDESIN SULFATE. | |
| FR2664598A1 (en) | PROCESS FOR THE PREPARATION OF SULFINYL PRISTINAMYCIN IIB. | |
| BE837804A (en) | DERIVATIVES OF THIOPHENE OR FURANNE AND PROCESS FOR THEIR PREPARATION | |
| FR2504531A1 (en) | PROCESS FOR THE PREPARATION OF VINCAMINIC ACID DERIVATIVES BY OXIDATIVE TRANSPOSITION OF TABERSONINE OR DIHYDROTABERSONINE | |
| BE831941A (en) | NEW ANTIBIOTIC AND ITS PREPARATION PROCESS | |
| BE835297A (en) | NEW DIAZEPINES AND PROCESS FOR PRODUCING THEM | |
| CH598285A5 (en) | Steroid 21-(4-acetamidomethylcyclohexane carboxylates) |